INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $138,000 | +43.8% | 30,313 | +9.0% | 0.00% | – |
Q4 2018 | $96,000 | -95.8% | 27,803 | -87.7% | 0.00% | -100.0% |
Q3 2018 | $2,271,000 | +35.3% | 225,395 | -2.8% | 0.00% | – |
Q2 2018 | $1,678,000 | +199.6% | 231,831 | +149.2% | 0.00% | – |
Q1 2018 | $560,000 | +8.7% | 93,034 | +72.8% | 0.00% | – |
Q4 2017 | $515,000 | +134.1% | 53,827 | +116.1% | 0.00% | – |
Q3 2017 | $220,000 | -80.8% | 24,904 | -72.5% | 0.00% | -100.0% |
Q2 2017 | $1,144,000 | +65.1% | 90,522 | +36.8% | 0.00% | 0.0% |
Q1 2017 | $693,000 | -42.6% | 66,155 | -49.6% | 0.00% | 0.0% |
Q4 2016 | $1,207,000 | -45.5% | 131,379 | -30.2% | 0.00% | -50.0% |
Q3 2016 | $2,216,000 | +0.1% | 188,106 | +9.9% | 0.00% | 0.0% |
Q2 2016 | $2,214,000 | +30.5% | 171,143 | +61.3% | 0.00% | +100.0% |
Q1 2016 | $1,696,000 | -63.3% | 106,108 | -34.3% | 0.00% | -66.7% |
Q4 2015 | $4,624,000 | +35.6% | 161,556 | +34.7% | 0.00% | 0.0% |
Q3 2015 | $3,410,000 | -19.8% | 119,914 | +1.2% | 0.00% | 0.0% |
Q2 2015 | $4,254,000 | +12.7% | 118,478 | +82.3% | 0.00% | +50.0% |
Q1 2015 | $3,776,000 | +51.0% | 64,990 | +9.5% | 0.00% | 0.0% |
Q4 2014 | $2,501,000 | +241.7% | 59,335 | +213.8% | 0.00% | – |
Q3 2014 | $732,000 | +83.5% | 18,911 | +47.3% | 0.00% | – |
Q2 2014 | $399,000 | -81.4% | 12,837 | -75.2% | 0.00% | -100.0% |
Q1 2014 | $2,147,000 | +669.5% | 51,844 | +618.6% | 0.00% | – |
Q4 2013 | $279,000 | -76.0% | 7,215 | -78.3% | 0.00% | -100.0% |
Q3 2013 | $1,163,000 | – | 33,284 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |